product summary
Loading...
company name :
Jackson ImmunoResearch Laboratories
product type :
secondary antibody
product name :
Rhodamine (TRITC) AffiniPure™ Sheep Anti-Mouse IgG (H+L)
catalog :
515-025-003
quantity :
2 mg
price :
98 USD
more info or order :
citations: 2
Reference |
---|
Klein A, Guhl E, Zollinger R, Tzeng Y, Wessel R, Hummel M, et al. Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. J Mol Med (Berl). 2005;83:362-76 pubmed
|
Klein A, Guhl E, Tzeng Y, Fuhrhop J, Levrero M, Graessmann M, et al. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Oncogene. 2003;22:2910-9 pubmed
|
product information
Catalog Number :
515-025-003
Product Name :
Rhodamine (TRITC) AffiniPure™ Sheep Anti-Mouse IgG (H+L)
Product Type :
Secondary Antibody
Host Species :
Sheep
Clonality :
Polyclonal
Conjugation :
Rhodamine (TRITC)
Size :
2 mg
USD List Price :
98 USD
Euro List Price :
129
Product Description :
Based on immunoelectrophoresis and/or ELISA, the antibody reacts with whole molecule mouse IgG. It also reacts with the light chains of other mouse immunoglobulins. No antibody was detected against non-immunoglobulin serum proteins. The antibody may cross-react with immunoglobulins from other species.
CrossReactivity :
Mouse
Specificity :
IgG (H+L)
more info or order :
company information

Jackson ImmunoResearch Laboratories
872 West Baltimore Pike West Grove, PA, 19390
cuserv@jacksonimmuno.com
http://www.jacksonimmuno.com1-800-367-5296
headquarters: USA
browse more products
- Rhodamine (TRITC) AffiniPure™ Sheep Anti-Mouse IgG (H+L) (min X Hu, Bov, Hrs ...
- Rhodamine (TRITC) AffiniPure™ Sheep Anti-Mouse IgG, Fcγ fragment specific (m ...
- Rhodamine (TRITC) AffiniPure™ Sheep Anti-Mouse IgG, F(ab')2 fragment specific ...
- Peroxidase AffiniPure™ Sheep Anti-Mouse IgG (H+L) | 515-035-003
- Peroxidase AffiniPure™ Sheep Anti-Mouse IgG (H+L) (min X Hu, Bov, Hrs Sr Pro ...
questions and comments